Top Markets
#1 Black Phoenix Black Phoenix +733.91%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.97%
#3 MetaDAO MetaDAO +18.10%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +17.27%
#5 Verus Coin Verus Coin +13.96%
#6 Derive Derive +9.22%
#7 Akedo Akedo +7.18%
#8 Tokamak Network Tokamak Network +6.76%
#9 XYO Network XYO Network +6.74%
#10 wojak wojak +4.57%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Hualan Biological Engineering Inc. Hualan Biological Engineering Inc.

Hualan Biological Engineering Inc.

002007
Classifica tra le azioni #4596
Hualan Biological Engineering Inc. operates as a biopharmaceutical company,... Hualan Biological Engineering Inc. operates as a biopharmaceutical company, specializing in the research, development, production, and commercialization of a diverse portfolio of medical products within the People's Republic of China. Its offerings span plasma-derived therapies, various viral and bacterial vaccines, recombinant proteins, and other advanced biologics. The company's extensive range of plasma products includes essential components like human albumin, a broad spectrum of human immunoglobulins (such as intravenous, rabies, hepatitis B, and tetanus formulations), and vital coagulation factors like human prothrombin complex and factor VIII. Hualan also provides specialized solutions such as lyophilized human thrombin for external use and surgical fibrin glue. In its vaccine division, Hualan offers critical immunizations, including several influenza vaccines (e.g., split virus, A H1N1, and quadrivalent forms), recombinant hepatitis B vaccine, and ACYW135 meningococcal polysaccharide vaccine. The company actively pursues strategic collaborations with key scientific organizations, most notably the Chinese Academy of Sciences, as well as other esteemed research institutes and enterprises. Established in 1992, Hualan Biological Engineering Inc. is headquartered in Xinxiang, People's Republic of China.
Prezzo delle azioni
$1.92
Ultima sincronizzazione: 2026-08-26
Capitalizzazione di mercato
$3.51B
Variazione (1 giorno)
1.07%
Variazione (1 anno)
-21.83%
Paese
CN
Scambia Hualan Biological Engineering Inc. (002007)

Categoria

Healthcare
Utile per Hualan Biological Engineering Inc. (002007)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Hualan Biological Engineering Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Hualan Biological Engineering Inc. dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH